Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yijingsheng capsule for cancer-related fatigue after adjuvant chemotherapy in lung cancer
CTR20200340Phase 2Active
- Sponsor
- Zhejiang Yake Pharmaceutical
- Start
- Mar 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Yijinsheng in cancer-related fatigue (CRF), bronchial carcinoma, sponsored by Zhejiang Yake Pharmaceutical. Started Mar 2020; status: active.
02
Drugs
Yijinsheng
03
Conditions
cancer-related fatigue (CRF)bronchial carcinoma
Beyond the preview
Go deeper on CTR20200340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200340.